发明名称 Heteroannelated anthraquinone derivatives for inhibiting cancers
摘要 Methods and pharmaceutical compositions for treating cancer utilizing compounds characterized by the following structure:; and their pharmaceutically acceptable salts.
申请公布号 US8772321(B2) 申请公布日期 2014.07.08
申请号 US201113325852 申请日期 2011.12.14
申请人 National Defense Medical Center 发明人 Huang Hsu-Shan;Chen Tsung-Chih;Cha Tai-Lung
分类号 A61K31/428;C07D285/14 主分类号 A61K31/428
代理机构 Muncy, Geissler, Olds & Lowe, P.C. 代理人 Muncy, Geissler, Olds & Lowe, P.C.
主权项 1. A method for treating cancer in a mammalian subject in need thereof, consisting of: inducing apoptosis, inhibiting cancer cell proliferation, or inhibiting telomerase activity in cancer cells of the mammalian subject by administering to the mammalian subject an effective amount of a pharmaceutical composition comprising: a compound having the formula (I): or pharmaceutically acceptable salts thereof; anda pharmaceutically acceptable carrier, a diluent, an excipient, or a combination thereof.
地址 Taipei TW